Colchicine and Pitavastatin Interaction

Drug interaction information between Colchicine and Pitavastatin.

Colchicine and Pitavastatin have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Colchicine and Pitavastatin. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Colchicine

Anti-Gout Agent

Drug B

Pitavastatin

HMG-CoA Reductase Inhibitor (Statin)

How They Interact

Taking these two drugs together can increase the risk of serious muscle damage.

FDA Label Information

Colchicine Clinical Impact: Cases of myopathy and rhabdomyolysis have been reported with concomitant use of colchicine with statins, including pitavastatin tablets. Intervention: Consider the risk/benefit of concomitant use of colchicine with pitavastatin tablets.

Frequently Asked Questions

What SPL severity band is on file for Colchicine + Pitavastatin?

Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Colchicine has 28 labeled pairs on file vs Pitavastatin's 9. In the moderate band specifically: Colchicine has 9 (also Atorvastatin, Ezetimibe, Ezetimibe/Simvastatin, Fenofibrate); Pitavastatin has 4 (also Gemfibrozil, Niacin, Sofosbuvir/Velpatasvir).

What mechanism field is on file for Colchicine and Pitavastatin?

Taking these two drugs together can increase the risk of serious muscle damage.

Colchicine carries more major-labeled pairs than Pitavastatin

SPL source-record counts only. This page's band is moderate · classes on file: Colchicine (Anti-Gout Agent); Pitavastatin (HMG-CoA Reductase Inhibitor (Statin)).

Colchicine has 4 major-labeled pairs vs Pitavastatin's 3. This page itself is in the moderate band, not the major band.

Colchicine

4 major · 9 moderate · 15 minor · 28 total

Pitavastatin

3 major · 4 moderate · 2 minor · 9 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.